1Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H,Beauvillain JC, et al. Cloning of the cDNA encoding the urotensinⅡ precursor in frog and human reveals intense expression of the urotensin Ⅱ gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 1998; 95: 15803-8.
2Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV,Romanic AM, et al. Human urotensin-Ⅱ is a potent vasoconstrictor and agonist for the orphan receptor GPRI4. Nature 1999, 401: 282-6.
3Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A. Congestive heart failure and expression of myocardial urotensin Ⅱ. Lancet 2002; 359: 1990-7.
4Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, et al. Urotensin-Ⅱ-mediated cardiomyocyte hypertrophy:effect of receptor antagonism and role of inflammatory mediators.Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 238-50.
5Egginger JG, Camus A, Calas A. Urotensin-Ⅱ expression in the mouse spinal cord. J Chem Neuroanat 2006; 31: 146-54.
6Zhang YG, Qi YF, Xia CF, Pang YZ, Yang J, Zhang ZK, et al.Stimulating proliferation of aorta smooth muscle cells of rat byurotensin Ⅱ. Chin Pharmacol Bull 2001; 17: 155-7.
7Shi L, Ding W, Li D, Wang Z, Jiang H, Zhang J, et al. Proliferation and anti-apoptotic effects of human urotensin Ⅱon human endothelial cells. Atherosclerosis 2006; 188: 260-4.
8Watanabe T, Suguro T, Kanome T, Sakamoto Y, Kodate S,Hagiwara T, et al. Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages. Hypertension 2005; 46: 738-44.
9Russell FD, Molenaar P. Investigation of signaling pathways that mediate the inotropic effect of urotensin-Ⅱ in human heart. Cardiovasc Res 2004; 63:673-81.
10Gruson D, Rousseau MF, Ahn SA, van Linden F, Ketelslegers JM. Circulating urotensin Ⅱ levels in moderate to severe congestive heart failure: Its relations with myocardial function and well established neurohormonal markers. Peptides 2006; 27: 1527- 31.
